Balyasny Asset Management LLC Stoke Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.07 - $15.69 $124,488 - $276,269	17,608 Added 154.05%	29,038 $268,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $143,560 - $257,517	11,430 New	11,430 $147,000
Q4 2021 Feb 14, 2022	SELL	$18.11 - $30.72 $1.11 Million - $1.87 Million	-61,031 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$23.65 - $34.44 $89,255 - $129,976	-3,774 Reduced 5.82%	61,031 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$30.53 - $41.09 $1.98 Million - $2.66 Million	64,805 New	64,805 $2.18 Million

129

55.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $447M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.